Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.

Ataie-Kachoie P, Badar S, Morris DL, Pourgholami MH

Open source

DOI
10.1158/1541-7786.mcr-13-0239
Published
2013 Oct
Container
Molecular cancer research : MCR
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1541-7786.mcr-13-0239,
  title = {Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.},
  author = {Ataie-Kachoie P and Badar S and Morris DL and Pourgholami MH},
  year = {2013},
  journal = {Molecular cancer research : MCR},
  doi = {10.1158/1541-7786.mcr-13-0239},
  url = {https://doi.org/10.1158/1541-7786.mcr-13-0239}
}

RIS

TY  - JOUR
TI  - Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.
AU  - Ataie-Kachoie P
AU  - Badar S
AU  - Morris DL
AU  - Pourgholami MH
PY  - 2013
JO  - Molecular cancer research : MCR
DO  - 10.1158/1541-7786.mcr-13-0239
UR  - https://doi.org/10.1158/1541-7786.mcr-13-0239
ER  - 

APA

P, A., S, B., DL, M., & MH, P. (2013). Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.. Molecular cancer research : MCR. https://doi.org/10.1158/1541-7786.mcr-13-0239

Source records